SFMN - Oncologie RIV
Version Française
English Version
Computation of contact restriction time after radionuclide therapy
Results established on 29 January 2026
Mandatory elements to be specified
Radiopharmaceutical:
—
Iodine-131-0%-uptake
Iodine-131-5%-uptake
Iodine-131-25%-uptake
Iodine-131-Benign disease
PSMA-177Lu
PSMA-177Lu 4 cures
PSMA-177Lu 6 cures
Radium-223
NET 177Lu
NET 177Lu 4 cures
Microspheres-90Y
Microspheres-166Ho
Lipiodol-131I
MIBG 131I
Synovectomy-90Y
Synovectomy-186Re
Synovectomy-169Er
Choose the radiopharmaceutical
Dose rate at 1m at room exit
µSv/h
Patient size
*
cm
Effective half-life and scenario adapted to the patient
No
Yes
Effective half-life
*
d
Duration at X m
h
Distance X
m
Duration at 1 m (non-zero value required)
h
Distance 1 m
m
Dosimetric constraint
mSv
Benign thyroid disorders
No
Yes
Dysthyroidism - Activity administered
MBq
Pathology
Autonomous nodule
Multinodular goitre
Graves’ disease
Pathology to be specified (drop-down menu)
Dysthyroidism - Iodine uptake
estimated
measured
Dysthyroidism - Iodine uptake
%
Software Version 2.0 (2025-09-02)
Computation of contact restriction time
Retour au CNP-MN
